It is a heartbreaking problem.
The investigation indicates that about two thirds of American adults fight persistent belly problems such as gas, swelling and abdominal pain, and few seek medical help.
Some take matters in their own hands by maintaining a food diary to potential identification triggers, eating certain foods to track the appearance and frequency of intestinal movements or take a microbiome evaluation at home.
Gutid is a new test option that was officially launched earlier this year. The stool sample exam is designed to explore the delicate community of bacteria, viruses and fungi living in our intestines and highlights ways to improve it.
The diet, the special fiber intake, measurements such as antibiotics, age and lifestyle options influence the composition and diversity of intestinal bacteria.
Maintaining a healthy intestinal microbioma is crucial: imbalances have been left to irritable intestine syndrome (IBS), type 2 diabetes, obesity, dementia and equally certain cancers. Gutid occurs in the midst of a worrying increase in colorectal cancer diagnoses in people under 50.
“Everything that the microbioma does is very explainable, everything does and everything works as it should,” said Paul Denslow, CEO and co -founder of Inano Bio, to the post.
“We simply did not have the technology to see it in detail or with the integrity or with the request for precision of being processable,” he added. “And Gutid is really the first test in doing that.”
Intus Bio sells two intestinal ideas of Gutides nuclei ($ 399) focuses on the problems of the intestinal function, while the complete evaluation of the microbiome ($ 599) observes a broader aspect when deepening the intestine-cerebro axis, which plays an important role.
But while DIY microbiome tests have become more popular, some researchers have thrown doubts about their value. A gastroenterologist last year compared them with “snake oil” and complained that “they generally lead to more questions than answers.”
Denslow said the method supported by Gutid’s science produces precise and consistent results when repeated with the same sample.
They are accredited by the Bacterial DNA sequencing technology of Gutid, of the Pacbio Life Science Technology Company, for providing a detailed visualization of the bacterial population of the intestine to the level of deformation.
At the World Biohackers Conference last month, Denslow highlighted the case of a person with serious problems of intestinal function struggling to find answers.
“Other evidence had tasks,” Denslow told the audience. “The tests are hurting something in particular, but with the resolution we have, with the complete results that we provide once again, the answer became a team.”
Denslow said Gutid can identify the failure conditions for other tests, such as bacterial infections of Mycoplasma.
You can buy online or tasks in a doctor’s office, with results in three to four weeks.
The report suggests foods, supplements, prebiotics and probiotics that could improve microbiome. Intus Bio does not sell these products because there is no unique approach and “the power of the test speaks for itself,” said Denslow. “We are selling data.”
Denslow recommends the tests once a year to establish a baseline and try again more frequently if the problems are marked.
Michael Gaumond, 73, listened about Gutid from his neighbor. I wanted to learn more about his “delicate stomach”, especially after undergoing colon surgery last year.
The Californian report recommended eliminating processed foods, meat and pork products, commercial salad dressings and carbohydrate rates such as potatoes, bread, cookies and fried potatoes.
He said he added salads with apple vinegar and extra virgin olive oil to his daily routine, as well as morning shakes and regular portions of fish and chicken breast. Hey, he also stopped snacks, especially before bedtime, and saw his increase in digestion problems.
“I pledged to follow the recommendations of the diet, and in a couple of weeks, I began to feel a positive difference,” Gaumond told the post. “For the next three or four months, I lost almost 40 pounds. I have 6 feet and 5 inches and weighed 285 pounds.”
Fara Erpamer, 60, was presented to the test through his son, who works to Intar Bio. She had long suffered from digestive problems.
Gutid found fusobacteria and other bacteria on his sample. That was a surprise that Aspamer had recovered cleaning in his colonoscopy 18 months before.
The Floridano brought the report to his gastroenterologist, who ordered a colonoscopy. A polyp was found and eliminated: the good news is that it was not cancerous.
“I guess I could be a bit partial since he works for the company,” Omensamer told The Post, “but I will say that my story could have had a different test and what I did not do the test and I waited a few years in search of another colonoscopy.”
Certain spasing strains have been strongly associated with colorectal cancer. The bacterium is found mainly in the mouth and can cause problems if it spreads to other tissues.
Denslow said some “very, very encouraging preliminary data” indicate that gutid technology can be used to diagnose diseases such as colorectal and pancreatic cans.
“We hope that a test will be launched in the next 12 to 18 months in the back of that work,” Denslow added.
“It really only talks about the fact that microbiome is this very, very powerful information space for health and health results, and we have this unique ability to look in that space and extract this information.”
